2 results
·
20ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 2
×
NUCLEIC ACID DETECTION IMMUNOASSAY (NADIA) PSA ASSAY
FDA 510(k)
FDA Class 2
·Immunology
Prostate-Specific Antigen (Psa) For Prognostic, Recurrence Risk Assessment Of Prostate Cancers
FDA classification
FDA Class 2
·Prostate-Specific Antigen (Psa) For Prognostic, Recurrence Risk Assessment Of Prostate Cancers